We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis outcomes revisited

    Neil Oldridge

    University of Wisconsin School of Medicine & Public Health, Aurora Cardiovascular Services, Aurora Medical Group, 6975 N Elm Tree Rd, Glendale, Milwaukee, WI 53217, USA.

    Published Online:https://doi.org/10.2217/fca.12.34

    Cardiac rehabilitation that includes either exercise training alone or exercise training in addition to psychosocial, risk factor management and/or educational interventions is considered a Class I indication [i.e., useful and effective] for patients with coronary heart disease. This overview of six independent cardiac rehabilitation meta-analyses published since 2000 includes a total of 71 randomized clinical trials (n = 13,824 patients) and clearly demonstrates significant clinical outcomes (reduced all-cause and cardiac mortality, nonfatal reinfarction and reduced hospitalization rates) and significant positive changes in modifiable risk factors (total cholesterol, triglycerides and systolic blood pressure). Despite the observation that the elderly, females, minority ethnic groups, low socioeconomic status patients and patients with comorbidities have not been well represented in the randomized clinical trials. Recent guidelines in the UK and USA have concluded with the recommendation that cardiac rehabilitation is reasonable and necessary and should be promoted by healthcare professionals, including senior medical staff.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References

    • World Health Organization Expert Committee on Rehabilitation: rehabilitation after cardiovascular diseases, with special emphasis on developing countries: report of a WHO Committee. World Health Organ. Tech. Rep. Ser.831,1–122 (1993).
    • Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation116(7),803–877 (2007).
    • Antman EM, Hand M, Armstrong PW et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines developed in collaboration with the Canadian Cardiovascular Society. Circulation117(2),296–329 (2008).
    • Fraker TD Jr, Fihn SD, Gibbons RJ et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation116(23),2762–2772 (2007).
    • Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation124(23),2610–2642 (2011).
    • Levine GN, Bates ER, Blankenship JC et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation124(23),2574–2609 (2011).
    • Smith SC Jr, Benjamin EJ, Bonow RO et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation124(22),2458–2473 (2011).
    • Acute Coronary Syndrome Guidelines Working Group. Guidelines for the management of acute coronary syndromes 2006. Med. J. Aust.184(Suppl. 8),S9–S29 (2006).
    • Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J.28(13),1598–1660 (2007).
    • 10  Skinner JS, Cooper A, Feder GS. Secondary prevention for patients after a myocardial infarction: summary of NICE guidance. BMJ334(7603),1112–1113 (2007).
    • 11  Van De Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur. Heart J.29(23),2909–2945 (2008).
    • 12  American Association of Cardiac and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs (4th Edition). Human Kinetics, IL, USA (2004).
    • 13  National Heart Foundation of Australia and Australian Cardiac Rehabilitation Association. Recommended framework for cardiac rehabilitation ’04. National Heart Foundation of Australia (2004).
    • 14  Stone JA, Arthur HM. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention (2nd Edition), 2004: executive summary. Can. J. Cardiol.21(Suppl. D),3D–19D (2005).
    • 15  Piepoli MF, Corra U, Benzer W et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European Association of Cardiovascular prevention and rehabilitation. Eur. J. Cardiovasc. Prev. Rehabil.17(1),1–17 (2010).
    • 16  Liberati A, Altman D, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ339,B2700 (2009).
    • 17  Oldridge NB, Guyatt GH, Fischer M, Rimm AR. Cardiac rehabilitation after myocardial infarction: combining data from randomized clinical trials. JAMA260,945–980 (1988).▪ First of the published cardiac rehabilitation meta-analyses.
    • 18  O’Connor GT, Buring JE, Yusuf S et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation80(2),234–244 (1989).▪ The second of the published cardiac rehabilitation meta-analyses.
    • 19  Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst. Rev. (1),CD001800 (2001).▪▪ One of the cardiac rehabilitation meta-analyses published since 2000.
    • 20  Brown A, Taylor R, Noorani H, Stone J, Skidmore B. Exercise-based cardiac rehabilitation programs for coronary artery disease: a systematic clinical and economic review. Canadian Coordinating office for Health Technology Assessment. Technology report #34. (2003).▪▪ One of the cardiac rehabilitation meta-analyses published since 2000.
    • 21  Taylor RS, Brown A, Ebrahim S et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am. J. Med.116(10),682–692 (2004).▪▪ One of the cardiac rehabilitation meta-analyses published since 2000.
    • 22  Clark AM, Hartling L, Vandermeer B, Mcalister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann. Intern. Med.143(9),659–672 (2005).▪▪ This is one of the cardiac rehabilitation meta-analyses published since 2000.
    • 23  Heran B, Chen J, Ebrahim S et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst. Rev.(7),CD001800 (2011).▪▪ One of the cardiac rehabilitation meta-analyses published since 2000.
    • 24  Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J.162(4),571–584 (2011).▪▪ One of the cardiac rehabilitation meta-analyses published since 2000.
    • 25  Walter LC, Davidowitz NP, Heineken PA, Covinsky KE. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA291(20),2466–2470 (2004).
    • 26  Grace SL, Chessex C, Arthur H et al. Systematizing inpatient referral to cardiac rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society joint position paper endorsed by the Cardiac Care Network of Ontario. Can. J. Cardiol.27(2),192–199 (2011).
    • 27  Gravely-Witte S, Leung YW, Nariani R et al. Effects of cardiac rehabilitation referral strategies on referral and enrollment rates. Nat. Rev. Cardiol.7(2),87–96 (2010).
    • 28  Bjarnason-Wehrens B, McGee H, Zwisler AD et al. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. Eur. J. Cardiovasc. Prev. Rehabil.17(4),410–418 (2010).
    • 29  Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation116(15),1653–1662 (2007).
    • 30  Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J. Am. Coll. Cardiol.54(1),25–33 (2009).
    • 31  Ades PA, Waldmann ML, McCann WJ, Weaver SO. Predictors of cardiac rehabilitation participation in older coronary patients. Arch. Intern. Med.152(5),1033–1035 (1992).
    • 32  Cooper AF, Jackson G, Weinman J, Horne R. Factors associated with cardiac rehabilitation attendance: a systematic review of the literature. Clin. Rehabil.16(5),541–552 (2002).
    • 33  Jackson L, Leclerc J, Erskine Y, Linden W. Getting the most out of cardiac rehabilitation: a review of referral and adherence predictors. Heart91(1),10–14 (2005).
    • 34  Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ328(7433),189 (2004).
    • 35  Haykowsky MJ, Liang Y, Pechter D, Jones LW, McAlister FA, Clark AM. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. J. Am. Coll. Cardiol.49(24),2329–2336 (2007).
    • 36  Hwang R, Marwick T. Efficacy of home-based exercise programmes for people with chronic heart failure: a meta-analysis. Eur. J. Cardiovasc. Prev. Rehabil.16(5),527–535 (2009).
    • 37  Davies EJ, Moxham T, Rees K et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur. J. Heart Fail.12(7),706–715 (2010).
    • 38  Davies EJ, Moxham T, Rees K et al. Exercise based rehabilitation for heart failure. Cochrane Database Syst. Rev.4,CD003331 (2010).
    • 39  Jolly K, Taylor RS, Lip GY, Stevens A. Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis. Int. J. Cardiol.111(3),343–351 (2006).
    • 40  Clark AM, Haykowsky M, Kryworuchko J et al. A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur. J. Cardiovasc. Prev. Rehabil.17(3),261–270 (2010).
    • 41  Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ340,B5631 (2010).
    • 42  Taylor RS, Dalal H, Jolly K, Moxham T, Zawada A. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst. Rev. (1),CD007130 (2010).
    • 43  Papadakis S, Oldridge N, Coyle D, Mayhew A, Reid R, Angus D. Economic evaluation of cardiac rehabilitation: a systematic review. Eur. J. Cardiovasc. Prev. Rehabil.12(6),513–520 (2005).
    • 44  Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control. Clin. Trials17(1),1–12 (1996).
    • 45  Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur. Heart J.31(6),642–648 (2010).
    • 46  Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med.3(11),E442 (2006).
    • 47  Giannuzzi P, Saner H, Bjornstad H et al. Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur. Heart J.24(13),1273–1278 (2003).
    • 48  Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam. Pract.19(6),596–604 (2002).
    • 49  Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation111(4),499–510 (2005).
    • 50  Barnhart J, Lewis V, Houghton JL, Charney P. Physician knowledge levels and barriers to coronary risk prevention in women: survey results from the Women and Heart Disease Physician Education Initiative. Womens Health Issues17(2),93–100 (2007).
    • 51  Jiang J, Hong T, Yu R, Zhang Y, Liu Z, Huo Y. Knowledge of secondary prevention guidelines for coronary heart disease: results from a physicians’ survey in China. Eur. J. Cardiovasc. Prev. Rehabil.13(3),231–238 (2011).
    • 52  Boyden T, Rubenfire M, Franklin B. Will increasing referral to cardiac rehabilitation improve participation? Prev. Cardiol.13(4),192–201 (2010).
    • 53  Thomas RJ, King M, Lui K, Oldridge N, Pina IL, Spertus J. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. Circulation116(14),1611–1642 (2007).
    • 54  Thomas RJ, King M, Lui K, Oldridge N, Pina IL, Spertus J. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of cardiovascular and pulmonary rehabilitation and the American College of Cardiology Foundation/American Heart Association task force on performance measures. Circulation122(13),1342–1350 (2010).
    • 55  Reeves GR, Whellan DJ. Recent advances in cardiac rehabilitation. Curr. Opin. Cardiol.25(6),589–596 (2010).
    • 56  Mazzini MJ, Stevens GR, Whalen D, Ozonoff A, Balady GJ. Effect of an American Heart Association Get With the Guidelines program-based clinical pathway on referral and enrollment into cardiac rehabilitation after acute myocardial infarction. Am. J. Cardiol.101(8),1084–1087 (2008).
    • 57  Brown TM, Hernandez AF, Bittner V et al. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association’s Get With the Guidelines program. J. Am. Coll. Cardiol.54(6),515–521 (2009).
    • 58  Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation109(9),1101–1107 (2004).
    • 59  Witt B, Jacobsen S, Weston S et al. Cardiac rehabilitation after myocardial infarction in the community. J. Am. Coll. Cardiol.988–996 (2004).
    • 60  Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation121(1),63–70 (2010).
    • 61  Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation123(21),2344–2352 (2011).
    • 62  Mills EJ, Wu P, Chong G et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. Q. J. Med.104(2),109–124 (2011).
    • 63  Lièvre M, Cucherat M. Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis. Fundam. Clin. Pharmacol.24,385–391 (2010).
    • 64  Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA290(1),86–97 (2003).
    • 65  Bueno H, Armstrong PW, Buxton MJ et al. The future of clinical trials in secondary prevention after acute coronary syndromes. Eur. Heart J.32(13),1583–1589 (2011).
    • 66  Menzin J, Wygant G, Hauch O, Jackel J, Friedman M. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr. Med. Res. Opin.24(2),461–468 (2008).
    • 67  Patel NB, Balady GJ. The rewards of good behavior. Circulation121(6),733–735 (2010).
    • 68  Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur. J. Cardiovasc. Prev. Rehabil.13(3),369–374 (2006).
    • 69  Teo KK, Ounpuu S, Hawken S et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet368(9536),647–658 (2006).
    • 70  Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet364(9438),937–952 (2004).
    • 71  Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Recent Smoking Cessation. Rockville, MD, USA (2010).
    • 72  Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet373(9667),929–940 (2009).
    • 73  Chow C, Jolly S, Rao-Melacini P, Fox K, Anand S, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation121,750–758 (2010).
    • 74  Lindson N, Aveyard P. An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl.)214(3),579–592 (2011).
    • 75  Hettema JE, Hendricks PS. Motivational interviewing for smoking cessation: a meta-analytic review. J. Consult. Clin. Psychol.78(6),868–884 (2010).
    • 76  Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst. Rev. (11),CD004492 (2010).
    • 77  Huttunen-Lenz M, Song F, Poland F. Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? meta-analysis of interventions. Br. J. Health. Psychol.15(Pt 4),749–777 (2010).
    • 78  Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev. (2),CD006103 (2011).
    • 79  Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, Dubose KD. Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med.31(15),1033–1062 (2001).
    • 80  Kelley GA, Kelley KS, Franklin B. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J. Cardiopulm. Rehabil.26(3),131–139 (2006).
    • 81  Kodama S, Tanaka S, Saito K et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Arch. Intern. Med.167(10),999–1008 (2007).
    • 82  Kelley GA, Kelley KS. Efficacy of aerobic exercise on coronary heart disease risk factors. Prev. Cardiol.11(2),71–75 (2008).
    • 83  Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J. Am. Coll. Cardiol.48(3),438–445 (2006).
    • 84  Ward S, Lloyd Jones M, Pandor A et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol. Assess.11(14),1–160, III–IV (2007).
    • 85  Spector R, Snapinn SM. Statins for secondary prevention of cardiovascular disease: the right dose. Pharmacology87(1–2),63–69 (2011).
    • 86  Lee LL, Watson MC, Mulvaney CA, Tsai CC, Lo SF. The effect of walking intervention on blood pressure control: a systematic review. Int. J. Nurs. Stud.47(12),1545–1561 (2010).
    • 87  Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med. Sci. Sports Exerc.33(Suppl. 6); Discussion S484–S493 (2001).
    • 88  Dickinson HO, Mason JM, Nicolson DJ et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J. Hypertens.24(2),215–233 (2006).
    • 89  Fagard RH, Cornelissen VA. Effect of exercise on blood pressure control in hypertensive patients. Eur. J. Cardiovasc. Prev. Rehabil.14(1),12–17 (2007).
    • 90  Bell CM, Urbach DR, Ray JG et al. Bias in published cost effectiveness studies: systematic review. BMJ332(7543),699–703 (2006).
    • 91  Yu CM, Lau CP, Chau J et al. A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention. Arch. Phys. Med. Rehabil.85(12),1915–1922 (2004).
    • 92  Oldridge N, Furlong W, Feeny D et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am. J. Cardiol.72(2),154–161 (1993).
    • 93  Briffa TG, Eckermann SD, Griffiths AD et al. Cost–effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial. Med. J. Aust.183(9),450–455 (2005).
    • 94  Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW. Community or patient preferences for cost–effectiveness of cardiac rehabilitation: does it matter? Eur. J. Cardiovasc. Prev. Rehabil.15(5),608–615 (2008).
    • 95  Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med.356(15),1503–1516 (2007).
    • 96  Heidenreich PA, Trogdon JG, Khavjou OA et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation123(8),933–944 (2011).
    • 97  Franco M, Ordunez P, Caballero B, Cooper RS. Obesity reduction and its possible consequences: what can we learn from Cuba’s Special Period? CMAJ178(8),1032–1034 (2008).
    • 98  Redfern J, Maiorana A, Neubeck L, Clark AM, Briffa T. Achieving coordinated secondary prevention of coronary heart disease for all in need (SPAN). Int. J. Cardiol.146(1),1–3 (2011).
    • 99  Balady GJ, Ades PA, Bittner VA et al. Referral, enrollment and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a Presidential Advisory from the American Heart Association. Circulation124(25),2951–2960 (2011).
    • 100  Neubeck L, Redfern J, Fernandez R, Briffa T, Bauman A, Freedman SB. Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur. J. Cardiovasc. Prev. Rehabil.16(3),281–289 (2009).
    • 101  Varnfield M, Karunanithi MK, Sarela A et al. Uptake of a technology-assisted home-care cardiac rehabilitation program. Med. J. Aust.194(4),S15–S19 (2011).
    • 102  Berra K, Miller NH, Jennings C. Nurse-based models for cardiovascular disease prevention: from research to clinical practice. Eur. J. Cardiovasc. Nurs.10(Suppl. 2),S42–S50 (2011).
    • 103  Dalal HM, Evans PH. Achieving national service framework standards for cardiac rehabilitation and secondary prevention. BMJ326(7387),481–484 (2003).
    • 104  Kodama S, Saito K, Tanaka S et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA301(19),2024–2035 (2009).
    • 105  Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N. Engl. J. Med.346(11),793–801 (2002).
    • 106  Rognmo O, Hetland E, Helgerud J, Hoff J, Slordahl SA. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur. J. Cardiovasc. Prev. Rehabil.11(3),216–222 (2004).
    • 107  Wisloff U, Stoylen A, Loennechen JP et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation115(24),3086–3094 (2007).
    • 108  Ades PA, Savage PD, Toth MJ et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation119(20),2671–2678 (2009).
    • 109  Hansen D, Dendale P, Van Loon LJ, Meeusen R. The impact of training modalities on the clinical benefits of exercise intervention in patients with cardiovascular disease risk or Type 2 diabetes mellitus. Sports Med.40(11),921–940 (2010).
    • 110  Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch. Intern. Med.164(5),493–501 (2004).
    • 111  Höfer S, Saleem A, Stone J, Thomas RJ, Tulloch H, Oldridge N. The MacNew heart disease health-related quality of life questionnaire in patients with angina and patients with ischemic heart failure. Value Health15,147–150 (2012).
    • 112  Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after myocardial infarction. Qual. Life Res.5(1),151–161 (1996).
    • 113  Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur. J. Prev. Cardiol. doi:10.1177/2047487312450544 (2012) (Epub ahead of print).
    • 114  Oldridge N, Höfer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: Part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur. J. Prev. Cardiol. doi:10.1177/2047487312450545 (2012) (Epub ahead of print).
    • 201  NICE: Clinical Guideline 48. MI: secondary prevention in primary and secondary care for patients following a myocardial infarction. www.nice.org.uk/CG48(Accessed 16 May 2011).
    • 202  Centers for Medicare and Medicaid Services: decision memo for cardiac rehabilitation services. US Department of Health and Human Services. www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=164&ver=12&NcaName=Cardiac+Rehabilitation+Programs&DocID=CAG-00089R&SearchType=Advanced&bc=IAAAAAgAIAAA& (Accessed 16 May 2011)
    • 203  British Association for Cardiac Rehabilitation in Affiliation with the British Cardiovascular Society. Standards and core components for cardiac rehabilitation. www.bacpr.com (Accessed 16 July 2011)
    • 204  NICE. The guidelines manual. www.nice.org.uk (Accessed 16 May 2011)
    • 205  Higgins J, Green S (Eds). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). www.cochrane-handbook.org (Accessed 16 July 2011)
    • 206  West R. Background smoking cessation rates in England. www.smokinginengland.info/Ref/paper2.pdf (Accessed 21 August 2011)